10-Q quarterly report · filed Nov 3, 2026

Pulmonx Corp (LUNG) Q3 2026 10-Q Quarterly Report

Short answer

Pulmonx Corp (LUNG) filed its Q3 2026 10-Q quarterly report on Nov 3, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $23M (up 6.2% year over year) with net income of −$8M.

Q3 2026 key financials · XBRL

Revenue
$23M
+6.2% YoY · +0.3% QoQ
Net income
−$8M
+39.9% YoY · +16.7% QoQ
Operating margin
-32.8%
Gross margin
76.2%
EPS (diluted)
−$0.20
+41.2% YoY · +13.0% QoQ

Source: XBRL data from the Pulmonx Corp (LUNG) Q3 2026 10-Q on SEC EDGAR. USD.

Pulmonx Corp Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $22.8M, up 6.2% YoY from $21.5M, driven by Zephyr Valve procedure volumes
  • Gross margin 76.2% vs 74.7% YoY, reflecting geographic mix changes
  • U.S. revenue $14.9M vs $14.0M, international revenue $7.9M vs $7.5M
  • Cash $52.7M, operating cash outflow $18.5M through nine months, versus $25.3M YoY
  • Outlook: cash funding for at least 12 months, continued net losses and substantial additional funding needs expected

Risk Factors

  • Newly added cybersecurity risk: January 2025 Intelerad vendor incident, despite no impact to Pulmonx’s LungTraX account or network
  • Most material update, trade risk: new U.S. tariffs and retaliatory measures could raise costs, with fixed pricing limiting pass-through for up to 36 months
  • Regulatory risk: CMS could establish coverage restrictions through a national or local coverage determination for endobronchial valves
  • Operational risk: $40.0 million Perceptive debt introduces covenant-breach risk and potential immediate repayment
  • Financial risk: $52.7 million cash and cash equivalents expected to fund operations for at least the next twelve months, subject to estimates

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Pulmonx Corp quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.